Follow the קמהדע share price and the full directors' dealings record of the company, a publicly traded company based in Israel. Shares trade on the IL market, under the supervision of TASE (ISA). The latest transaction was filed on 18 June 2026 (Holding). Among the most active insiders: רקנאטי ליאון. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
Kamada is a biopharmaceutical company focused on the development and commercialization of therapeutic products based on proteins. It is listed on the Tel Aviv Stock Exchange.